HK1182617A1 - 用以治療血管滲透性過高的二酮哌嗪 - Google Patents
用以治療血管滲透性過高的二酮哌嗪Info
- Publication number
- HK1182617A1 HK1182617A1 HK13109875.6A HK13109875A HK1182617A1 HK 1182617 A1 HK1182617 A1 HK 1182617A1 HK 13109875 A HK13109875 A HK 13109875A HK 1182617 A1 HK1182617 A1 HK 1182617A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- diketopiperazines
- treating vascular
- vascular hyperpermeability
- hyperpermeability
- treating
- Prior art date
Links
- 230000002792 vascular Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38040410P | 2010-09-07 | 2010-09-07 | |
| PCT/US2011/050612 WO2012033789A2 (en) | 2010-09-07 | 2011-09-07 | Treatment of diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1182617A1 true HK1182617A1 (zh) | 2013-12-06 |
Family
ID=45771136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK13109875.6A HK1182617A1 (zh) | 2010-09-07 | 2013-08-23 | 用以治療血管滲透性過高的二酮哌嗪 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20120058934A1 (zh) |
| EP (1) | EP2613795B1 (zh) |
| JP (2) | JP5941047B2 (zh) |
| KR (1) | KR101822951B1 (zh) |
| CN (1) | CN103200952B (zh) |
| AU (1) | AU2011299353B2 (zh) |
| BR (1) | BR112013005432A8 (zh) |
| CA (1) | CA2810834C (zh) |
| CO (1) | CO6710904A2 (zh) |
| EA (1) | EA023932B1 (zh) |
| ES (1) | ES2611878T3 (zh) |
| HK (1) | HK1182617A1 (zh) |
| IL (1) | IL224931A (zh) |
| MX (1) | MX343160B (zh) |
| NZ (1) | NZ607600A (zh) |
| SG (2) | SG10201507120TA (zh) |
| WO (1) | WO2012033789A2 (zh) |
| ZA (1) | ZA201301601B (zh) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1311269B1 (en) | 2000-08-04 | 2012-02-29 | DMI Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
| ES2572975T3 (es) * | 2003-05-15 | 2016-06-03 | Ampio Pharmaceuticals, Inc. | Tratamiento de enfermedades mediadas por los linfocitos T |
| US8217047B2 (en) | 2008-05-27 | 2012-07-10 | Dmi Acquisition Corp. | Therapeutic methods and compounds |
| SG10201507120TA (en) * | 2010-09-07 | 2015-10-29 | Ampio Pharmaceuticals Inc | Treatment of diseases |
| JP2013537195A (ja) | 2010-09-07 | 2013-09-30 | ディエムアイ アクイジション コーポレイション | 疾患の治療 |
| CN103841987B (zh) | 2011-10-10 | 2015-06-17 | 安皮奥制药股份有限公司 | 退行性关节病的治疗 |
| MX2014003856A (es) | 2011-10-10 | 2015-01-16 | Ampio Pharmaceuticals Inc | Dispositivos medicos implantables con tolerancia inmune incrementada y metodos para hacerlos e implantarlos. |
| SG10201605205VA (en) | 2011-10-28 | 2016-08-30 | Ampio Pharmaceuticals Inc | Treatment of rhinitis |
| EP2968315B1 (en) | 2013-03-15 | 2020-06-03 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
| US20160106130A1 (en) | 2013-06-10 | 2016-04-21 | Suntory Holdings Limited | Plant extract containing diketopiperazine and method for producing same |
| CN103913853A (zh) * | 2013-07-05 | 2014-07-09 | 马准吾 | 具备冷感包覆层的隐形眼镜 |
| EP3183240A4 (en) | 2014-08-18 | 2018-06-27 | Ampio Pharmaceuticals, Inc. | Treatment of joint conditions |
| US11389512B2 (en) | 2015-06-22 | 2022-07-19 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
| KR20180030915A (ko) | 2015-07-27 | 2018-03-26 | 산토리 홀딩스 가부시키가이샤 | 고리형 디펩티드 및 감미료를 함유하는 조성물 |
| KR102396603B1 (ko) | 2015-09-16 | 2022-05-11 | 원광대학교산학협력단 | 시트룰린을 유효성분으로 함유하는 간 기능 개선용 조성물 |
| CN105879005A (zh) * | 2016-02-01 | 2016-08-24 | 四川好医生攀西药业有限责任公司 | 一种治疗溃疡性结肠炎的药物组合物及其制备方法和应用 |
| CN109563150A (zh) * | 2016-07-26 | 2019-04-02 | 安皮奥制药股份有限公司 | 由血管高通透性介导的疾病的治疗 |
| CN111033637B (zh) | 2017-08-08 | 2023-12-05 | 费森尤斯医疗保健控股公司 | 用于治疗和评估慢性肾脏疾病的进程的系统和方法 |
| JP6741280B2 (ja) * | 2018-03-29 | 2020-08-19 | 株式会社ウォーターエージェンシー | Ａｃｅ阻害、血圧上昇抑制、又は血圧降下に用いられる組成物、及びその製造方法 |
| WO2021195265A1 (en) | 2020-03-24 | 2021-09-30 | Ampio Pharmaceuticals, Inc. | Methods for treating diseases associated with respiratory viruses |
| CN113754598B (zh) * | 2021-09-29 | 2023-06-06 | 四川大学 | 含环肽结构的二胺、聚酰亚胺及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000327575A (ja) * | 1999-05-26 | 2000-11-28 | Teika Seiyaku Kk | ジケトピペラジン誘導体含有炎症疾患治療剤および新規なジケトピペラジン誘導体 |
| EP1311269B1 (en) * | 2000-08-04 | 2012-02-29 | DMI Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
| CN1791420A (zh) * | 2003-05-15 | 2006-06-21 | Dmi生物科学公司 | T－细胞介导的疾病的治疗 |
| ES2572975T3 (es) * | 2003-05-15 | 2016-06-03 | Ampio Pharmaceuticals, Inc. | Tratamiento de enfermedades mediadas por los linfocitos T |
| MX2010003113A (es) * | 2007-09-25 | 2010-04-01 | Abbott Lab | Compuestos de octahidropentaleno como antagonistas del receptor de quimiocina. |
| US8217047B2 (en) * | 2008-05-27 | 2012-07-10 | Dmi Acquisition Corp. | Therapeutic methods and compounds |
| SG10201507120TA (en) * | 2010-09-07 | 2015-10-29 | Ampio Pharmaceuticals Inc | Treatment of diseases |
| JP2013537195A (ja) * | 2010-09-07 | 2013-09-30 | ディエムアイ アクイジション コーポレイション | 疾患の治療 |
-
2011
- 2011-09-07 SG SG10201507120TA patent/SG10201507120TA/en unknown
- 2011-09-07 EA EA201390347A patent/EA023932B1/ru not_active IP Right Cessation
- 2011-09-07 SG SG2013015680A patent/SG187986A1/en unknown
- 2011-09-07 BR BR112013005432A patent/BR112013005432A8/pt not_active IP Right Cessation
- 2011-09-07 CN CN201180053553.8A patent/CN103200952B/zh active Active
- 2011-09-07 AU AU2011299353A patent/AU2011299353B2/en not_active Ceased
- 2011-09-07 CA CA2810834A patent/CA2810834C/en not_active Expired - Fee Related
- 2011-09-07 KR KR1020137008193A patent/KR101822951B1/ko active IP Right Grant
- 2011-09-07 ES ES11824038.1T patent/ES2611878T3/es active Active
- 2011-09-07 EP EP11824038.1A patent/EP2613795B1/en active Active
- 2011-09-07 JP JP2013528256A patent/JP5941047B2/ja not_active Expired - Fee Related
- 2011-09-07 NZ NZ607600A patent/NZ607600A/en not_active IP Right Cessation
- 2011-09-07 US US13/227,098 patent/US20120058934A1/en not_active Abandoned
- 2011-09-07 MX MX2013002566A patent/MX343160B/es active IP Right Grant
- 2011-09-07 WO PCT/US2011/050612 patent/WO2012033789A2/en active Application Filing
-
2013
- 2013-02-26 IL IL224931A patent/IL224931A/en active IP Right Grant
- 2013-03-01 ZA ZA2013/01601A patent/ZA201301601B/en unknown
- 2013-04-05 CO CO13089531A patent/CO6710904A2/es unknown
- 2013-08-23 HK HK13109875.6A patent/HK1182617A1/zh not_active IP Right Cessation
-
2016
- 2016-05-19 JP JP2016100487A patent/JP2016145261A/ja active Pending
-
2019
- 2019-09-25 US US16/582,953 patent/US20200016152A1/en not_active Abandoned
-
2020
- 2020-11-05 US US17/090,673 patent/US20210052578A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR112013005432A2 (pt) | 2016-06-07 |
| EP2613795A2 (en) | 2013-07-17 |
| ZA201301601B (en) | 2018-12-19 |
| JP5941047B2 (ja) | 2016-06-29 |
| BR112013005432A8 (pt) | 2017-12-05 |
| MX343160B (es) | 2016-10-26 |
| CA2810834C (en) | 2017-03-21 |
| NZ607600A (en) | 2015-05-29 |
| EP2613795A4 (en) | 2013-10-30 |
| ES2611878T3 (es) | 2017-05-11 |
| AU2011299353A1 (en) | 2013-03-14 |
| IL224931A (en) | 2017-05-29 |
| EA201390347A1 (ru) | 2013-07-30 |
| WO2012033789A2 (en) | 2012-03-15 |
| JP2013537194A (ja) | 2013-09-30 |
| CO6710904A2 (es) | 2013-07-15 |
| JP2016145261A (ja) | 2016-08-12 |
| SG10201507120TA (en) | 2015-10-29 |
| CA2810834A1 (en) | 2012-03-15 |
| US20210052578A1 (en) | 2021-02-25 |
| CN103200952A (zh) | 2013-07-10 |
| KR20140003399A (ko) | 2014-01-09 |
| WO2012033789A3 (en) | 2012-05-31 |
| US20120058934A1 (en) | 2012-03-08 |
| EP2613795B1 (en) | 2016-10-26 |
| EA023932B1 (ru) | 2016-07-29 |
| SG187986A1 (en) | 2013-03-28 |
| KR101822951B1 (ko) | 2018-01-29 |
| CN103200952B (zh) | 2016-04-06 |
| US20200016152A1 (en) | 2020-01-16 |
| AU2011299353B2 (en) | 2016-02-25 |
| MX2013002566A (es) | 2013-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1182617A1 (zh) | 用以治療血管滲透性過高的二酮哌嗪 | |
| PL2652193T3 (pl) | Obróbka | |
| EP2611496A4 (en) | Methods of Treatment | |
| EP2554175A4 (en) | COMPOSITION FOR THE TREATMENT OF A DESIRED PART | |
| IL222702A0 (en) | Incontinence treatment | |
| HK1180258A1 (zh) | 探針 | |
| EP2629736A4 (en) | FABRIC TREATMENT | |
| HK1183831A1 (zh) | 探針 | |
| HUE044426T2 (hu) | HBV kezelés | |
| EP2574362A4 (en) | CATHETER | |
| EP2536483A4 (en) | PROCESS FOR TREATING SOLVENT | |
| EP2521569A4 (en) | COMBINATION THERAPY WITH VB-201 | |
| HK1184401A1 (zh) | 探針 | |
| IL220594A0 (en) | Treatment method | |
| HK1176321A1 (zh) | 探針 | |
| EP2642946A4 (en) | TREATMENT MEDIUM FOR VASCULAR BIFURCATIONS | |
| IL256026A (en) | Treatment methods | |
| EP2616186A4 (en) | MACHINING OF WOODEN PIECES | |
| HK1185292A1 (zh) | 無細胞血管產物 | |
| HK1183626A1 (zh) | 瘢痕疙瘩治療法 | |
| GB201013573D0 (en) | Treatment | |
| EP2560679A4 (en) | TREATMENT OF ECZEMA | |
| ZA201207496B (en) | Treatment of chicory | |
| GB201114901D0 (en) | Vascular treatments | |
| ZA201207497B (en) | Treatment of chicory |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200910 |